What is Tafluprost
Tafluprost is a prostaglandin analog with a high affinity for the fluoroprostaglandin (FP) receptor.
It is indicated for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
In clinical studies, administration of tafluprost 0.0015% once daily to patients with open-angle glaucoma or ocular hypertension and a baseline IOP of 23—26 mmHg resulted in an IOP decrease of approximately 6—8 mmHg after 3 months and 5—8 mmHg after 6 months.
- increased intraocular pressure
- ocular hypertension
For the reduction of increased intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
- blurred vision
- conjunctival hyperemia
- iridal discoloration
- macular edema
- ocular irritation
- ocular pain
- ocular pruritus
- skin hyperpigmentation
- intraocular pressure
- ophthalmologic exam
There are no drug interactions associated with Tafluprost products.